Remove Capital Remove Medical Remove Private Equity
article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Avista Acquires Terrats Medical

JD Supra: Mergers

Avista Capital Partners has announced it has acquired Terrats Medical from Miura Partners. Terrats, based in Barcelona, Spain, is a provider of dental prosthetics. The company sells into more than 50 countries. By: McGuireWoods LLP

Medical 152
article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Gainline Acquires M&M International

JD Supra: Mergers

Gainline Capital Partners has announced its acquisition of M&M International. M&M, founded in 1993 and based in South Plainfield, New Jersey, manufactures stainless steel tubing primarily for medical devices. By: McGuireWoods LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain to Sell ILC Dover for $2.3 Billion

JD Supra: Mergers

New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device markets and aerospace industries. billion, according to industry reports. ILC, founded in 1947 and based in Frederica, Del., By: McGuireWoods LLP

article thumbnail

How Private Equity uses ‘Roll-up’ Strategies to Drive Investment Returns

OfficeHours

In the pursuit of attractive equity returns, private equity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of private equity-backed roll-up activity.

article thumbnail

The Full Guide to Healthcare Private Equity, from Careers to Contradictions

Mergers and Inquisitions

When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?

article thumbnail

ENT & Allergy Practices Attract Private Equity

Focus Investment Banking

Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. ENT and allergy is relatively new to private equity investment, with approximately ten major platforms currently operating.

article thumbnail

Private Equity Interest in Orthopedics Grows

Focus Investment Banking

Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. Despite the recent rash of M&A deals, the orthopedic business, like other medical fields, remains highly fragmented.